Clinical Trial Update: Tumor Markers in Lung Cancer: DCAMLK-1LK-1 [NA]

View source ↗

Summary

The University of Oklahoma-sponsored clinical trial on tumor markers in lung cancer (NCT01578018) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University of Oklahoma | Conditions: Lung Cancer, Smoking | NA | Status: COMPLETED